Yes — internal family systems therapy works, with clinical evidence supporting its effectiveness for PTSD, depression, chronic pain, and emerging addiction applications. IFS therapy, developed by Dr. Richard Schwartz in the 1980s, treats the mind as a system of distinct internal “parts,” each with its own role, history, and emotional function. In 2015, SAMHSA’s National Registry of Evidence-Based Programs and Practices (NREPP) formally recognized IFS as an evidence-based practice — confirming it as effective for general functioning and well-being, and promising for depression, anxiety, physical health, and personal resilience (Foundation for Self Leadership, 2015).
Key Takeaways:
- SAMHSA’s NREPP classified IFS as evidence-based in 2015, rating it effective for general functioning and well-being, and promising for depression and anxiety.
- In a pilot effectiveness study, 92% of PTSD participants no longer met diagnostic criteria for PTSD at one-month follow-up after 16 IFS sessions, with a large effect size of d = −4.46 (Hodgdon et al., 2021).
- A 2024 clinical trial found a 16-week online group IFS program produced statistically significant reductions in PTSD symptom severity (d = −0.7, p = .005), alongside improvements in self-compassion and emotion regulation.
- A randomized controlled trial published in the Journal of Rheumatology (2013) found IFS reduced pain, improved physical function, and reduced depression in rheumatoid arthritis patients — with benefits sustained one year after treatment ended.
- IFS produced equivalent depression outcomes to CBT and interpersonal therapy in a randomized pilot study of female college students (Haddock et al., 2016).
- Reductions in depression represent the only condition where IFS has demonstrated statistically significant improvement across multiple pilot RCTs to date — more large-scale RCTs are still needed.
- A 2025 pilot study found IFS produced promising improvements in both PTSD and substance use outcomes in patients with comorbid PTSD and SUD (Ally et al., Frontiers in Psychiatry).
What Does Internal Family Systems Therapy Work For?

The evidence for whether internal family systems therapy works covers the following conditions and outcomes: PTSD and complex trauma, depression, chronic pain and physical health, addiction and comorbid substance use disorders, self-compassion and emotional regulation, and general psychological functioning and well-being. The strength of evidence varies by condition — IFS is most robustly supported for PTSD, depression, and trauma-related symptoms, with emerging pilot data for addiction and chronic illness.
What Is Internal Family Systems (IFS) Therapy?

Internal family systems therapy is an individual and group psychotherapy model that conceptualizes the mind as a plural internal system composed of multiple subpersonalities, or “parts.” Parts fall into two primary functional categories:
- Exiles — parts that carry emotional pain, shame, or traumatic memories, typically from early adverse experiences
- Protectors — parts that manage or suppress exiles to prevent overwhelming distress, subdivided into managers (proactive) and firefighters (reactive)
At the center of the IFS model is the Self — the individual’s core identity, characterized by calm, curiosity, compassion, and clarity. IFS therapy works by helping clients access the Self and establish an internal dialogue with their parts, with the goal of releasing the burdens those parts carry and restoring internal equilibrium. The model was developed by Dr. Richard Schwartz in the 1980s and draws on systems theory, mindfulness, self-compassion, and multiplicity-of-mind frameworks (Schwartz & Sweezy, 2020).
Is IFS Therapy Evidence-Based?
Yes — IFS therapy meets the standard for evidence-based practice, though its research base is still expanding. In 2015, SAMHSA’s NREPP conducted an independent, two-tier evaluation of IFS and formally recognized it as an evidence-based modality, based on a proof-of-concept RCT published in the Journal of Rheumatology (Foundation for Self Leadership, 2015). A 2025 scoping review of 27 peer-reviewed studies (Buys, Clinical Psychologist, 2025) confirmed that IFS has been studied across PTSD, depression, chronic pain, addiction, and other conditions, using case studies, quasi-experimental designs, and RCTs.
The IFS Institute acknowledges that well-designed RCTs with replication are still needed before IFS can be designated an evidence-based intervention for specific condition-by-condition indications — reductions in depression are currently the only outcome with statistically significant results across multiple pilot RCTs (IFS Institute).
Does IFS Therapy Work for PTSD and Trauma?

Yes — IFS therapy produces clinically significant reductions in PTSD symptoms, and current pilot data is among the strongest in the IFS research base. In a foundational pilot effectiveness study (Hodgdon et al., 2021, Journal of Aggression, Maltreatment & Trauma), 17 adults with PTSD and histories of multiple childhood traumas received 16 weekly 90-minute IFS sessions. Results showed:
- Large effect size reduction in PTSD symptom severity (d = −4.46 on CAPS; d = −3.05 on DTS)
- Significant reductions in depression (d = −1.51), dissociation, somatization, and affect dysregulation
- At one-month follow-up, 92% of participants no longer met diagnostic criteria for PTSD
A 2024 feasibility trial (Comeau et al., Psychological Trauma) delivered a 16-week hybrid IFS program (online group + individual sessions) to adults with PTSD in a community health setting. The trial produced statistically significant PTSD severity reductions (d = −0.7, p = .005), improvements in self-compassion and emotion regulation, and 92% of participants reported they would recommend the program. IFS treats trauma without requiring repeated direct exposure to traumatic memories, making it a clinically meaningful alternative for patients who do not fully respond to CPT or prolonged exposure.
Does IFS Therapy Work for Depression?
Yes — IFS therapy has produced statistically significant reductions in depressive symptoms across multiple studies. A randomized pilot study (Haddock et al., 2016, Journal of Marital and Family Therapy) randomized 37 female college students with depression to either IFS therapy or treatment as usual (CBT or interpersonal therapy). Both groups showed equivalent declines in depressive symptoms, providing early evidence that IFS is comparably effective to established evidence-based treatments for depression.
The PTSD pilot study (Hodgdon et al., 2021) also demonstrated a significant depression effect size of d = −1.51 as a secondary outcome. IFS is currently the only condition area where multiple pilot RCTs have demonstrated statistically significant improvement, according to the IFS Institute’s own research summary.
Does IFS Therapy Work for Chronic Pain and Physical Health?
Yes — a randomized controlled trial published in the Journal of Rheumatology (Shadick et al., 2013) is the strongest controlled study in the IFS evidence base. The trial randomized 79 patients with rheumatoid arthritis (RA) to either 9 months of group and individual IFS sessions (n = 39) or an educational control group (n = 40). Results at treatment end and 1-year follow-up included:
- Significant reduction in overall pain (p = 0.04) and improved physical function (p = 0.04)
- Sustained improvements in self-assessed joint pain (p = 0.04), self-compassion (p = 0.01), and depressive symptoms (p = 0.01) at one year
- 82% of the IFS group completed the full protocol
IFS reduces the emotional dysregulation and internal conflict that amplifies pain perception — a documented mechanism in chronic illness where psychological burden directly increases subjective pain and disease management difficulty.
Does IFS Therapy Work for Addiction and Substance Use?
Emerging evidence suggests yes — IFS shows promising results for comorbid PTSD and substance use disorders (SUD), which co-occur at high rates and are notoriously difficult to treat. A 2025 pilot feasibility study (Ally et al., Frontiers in Psychiatry) delivered a 12-week online group IFS program plus 6 individual IFS sessions to patients with comorbid PTSD and SUD.
The study exceeded pre-specified feasibility and acceptability targets, with participants reporting high satisfaction and retention, and preliminary improvements in both PTSD symptoms and substance use outcomes. IFS for addiction operates by addressing the internal “firefighter” parts that use substances to suppress emotional pain from exiled trauma — targeting the psychological root of substance use rather than only its behavioral symptoms (Anderson et al., 2017, IFS Skills Training Manual).
How Does IFS Compare to Other Therapies?
IFS compares favorably to CBT and interpersonal therapy for depression in the available pilot data, producing equivalent outcomes without requiring cognitive restructuring or behavioral activation techniques. Unlike CBT, IFS does not directly challenge thought patterns — it works by accessing the Self and facilitating internal dialogue, which some clients find more accessible when shame, dissociation, or complex trauma are present. IFS differs from prolonged exposure (PE) in that it does not require systematic re-exposure to traumatic memories, making it an important clinical alternative for trauma patients who cannot tolerate exposure-based methods. As of April 2024, 45,764 therapists listed IFS as a modality on PsychologyToday.com, reflecting substantial adoption in clinical practice ahead of its formal evidence base (Society for Psychotherapy, 2024).
Who Is IFS Therapy Best Suited For?
IFS therapy is best suited for individuals whose presenting conditions involve trauma, shame, internal conflict, self-criticism, or emotional dysregulation — particularly:
- Adults with PTSD, complex PTSD, or histories of childhood trauma
- Individuals with depression, especially those who have not fully responded to CBT or medication
- Women with trauma histories driving co-occurring addiction and mental health conditions
- Individuals with chronic pain or illness where psychological burden is a significant factor
- People seeking a non-pathologizing, compassion-centered approach to mental health
IFS is not recommended as a standalone intervention for individuals with active psychosis, severe mania, or poorly differentiated dissociative identity disorder without additional clinical scaffolding (Brownstone et al., Psychotherapy Bulletin, 2024).
What Are the Limitations of IFS Therapy?
The primary limitation of IFS therapy is its research base — while promising, the body of published RCTs remains small relative to the modality’s widespread clinical adoption. Most existing studies are pilot studies with small samples, limiting the statistical power needed to generalize findings. IFS does not uniformly improve all symptoms: the RA trial, for example, found no sustained improvements in anxiety, self-efficacy, or disease activity despite strong effects on pain and depression. Treatment duration is also a practical consideration — studied protocols typically involve 12–16 weekly sessions, which requires time commitment and therapeutic accessibility. Large-scale, condition-specific RCTs with replication are needed before IFS can be formally designated evidence-based for PTSD, addiction, or physical health conditions.
Summary
Internal family systems therapy works — clinical trials and pilot studies provide evidence supporting its effectiveness for PTSD, depression, chronic pain, and emerging addiction applications — though its research base is still developing and large-scale RCTs are needed to confirm condition-specific efficacy.
Worthy Wellness Center in Carlsbad, CA integrates internal family systems therapy into a comprehensive, trauma-informed treatment program for women navigating addiction and co-occurring mental health conditions. If you or someone you care about is struggling with trauma, substance use, or a dual diagnosis, Worthy Wellness Center can help.
Sources
- Foundation for Self Leadership — IFS Evidence & NREPP Recognition (2015): https://www.foundationifs.org/research
- Hodgdon et al. (2021) — IFS for PTSD Among Survivors of Multiple Childhood Trauma. Journal of Aggression, Maltreatment & Trauma: https://www.tandfonline.com/doi/full/10.1080/10926771.2021.2013375
- Shadick et al. (2013) — IFS RCT for Rheumatoid Arthritis. Journal of Rheumatology: https://www.jrheum.org/content/40/11/1831
- Comeau et al. (2024) — Online Group IFS for PTSD (PARTS Study). Psychological Trauma: Theory, Research, Practice, and Policy
- Haddock et al. (2016) — IFS for Depression in Female College Students. Journal of Marital and Family Therapy
- Buys (2025) — Scoping Review of IFS Evidence. Clinical Psychologist: https://www.tandfonline.com/doi/full/10.1080/13284207.2025.2533127
- Ally et al. (2025) — IFS for Comorbid PTSD and SUD. Frontiers in Psychiatry: https://pmc.ncbi.nlm.nih.gov/articles/PMC11983591/
- IFS Institute — Research Summary: https://ifs-institute.com/resources/research
- Brownstone, Hunsicker & Greene (2024) — IFS: Exploring Its Problematic Popularity. Psychotherapy Bulletin, 59(3): https://societyforpsychotherapy.org/internal-family-systems-exploring-its-problematic-popularity/
- IFS Institute (official research hub): https://ifs-institute.com/resources/research
- SAMHSA Behavioral Health Treatment Services: https://www.samhsa.gov/find-help/national-helpline


